OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS.
Sign Up to like & getrecommendations! Published in 2019 at "Retina"
DOI: 10.1097/iae.0000000000002451
Abstract: PURPOSE Mitogen-activates protein kinase (MAPK) inhibitors, particularly MEK inhibitors, have shifted the treatment paradigm for metastatic BRAF-mutant cutaneous melanoma; however, oncologists, ophthalmologists, and patients have noticed different toxicities of variable importance. This review aims to… read more here.
Keywords: mek inhibitors; ocular adverse; events associated; adverse events ... See more keywords